The Contrast Enhanced Ultrasound Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Contrast Enhanced Ultrasound Market?
The market size of the contrast enhanced ultrasound has experienced robust growth in past years. From 2024 to 2025, it is projected to increase from $2.05 billion to $2.16 billion, with a CAGR of 5.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Contrast Enhanced Ultrasound Industry?
The Contrast Enhanced Ultrasound Global Market is projected to grow to a size of $2.69 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%.
Download Your Free Sample of the 2025 Contrast Enhanced Ultrasound Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Contrast Enhanced Ultrasound Market?
The key drivers in the contrast enhanced ultrasound market are:
• Rise in cardiovascular diseases fueling the need for enhanced diagnostic techniques
• Increasing applications of contrast enhanced ultrasound in pediatric imaging
• Expanding role of this technology in gastrointestinal imaging
• Growing focus on precision medicine and integration with artificial intelligence.
Global Market Segmentation: Identifying Major Contrast Enhanced Ultrasound Industry Segments
The contrast enhanced ultrasound market covered in this report is segmented –
1) By Product: Equipment, Contrast Agent
2) By Technology: Non-targeted, Targeted
3) By Application: Hospitals, Clinics, Other Applications
Pre-order the 2025 Contrast Enhanced Ultrasound Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Contrast Enhanced Ultrasound Market?
The key trends in the contrast enhanced ultrasound market are:
• Continuous technological innovations are a key emerging trend in the contrast enhanced ultrasound market.
• There is an increasing trend towards the use of advancements in ultrasound technology.
• The market is seeing emerging trends in the expanding use of contrast ultrasound in oncology.
• The integration with multimodal imaging and real-time quantitative assessment in pediatric applications is becoming more prevalent.
Who Are the Top Competitors & Leading Players in the Contrast Enhanced Ultrasound Market?
Major companies in the contrast enhanced ultrasound market are:
• General Electric Company
• Bayer AG
• Bristol-Myers Squibb Company
• Siemens Healthcare GmbH
• Koninklijke Philips N.V.
• Daiichi Sankyo Company Limited
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• J.B. Chemicals and Pharmaceuticals Ltd.
• Canon Medical Systems
• Lantheus Medical Imaging Inc.
• Guerbet
• Bracco Diagnostic Inc.
• Esaote S.p.A.
• Trivitron Healthcare Pvt. Ltd.
• BK Medical Holding Company Inc.
• Hitachi Healthcare
• Chison Medical Technology Co. Ltd.
• SANOCHEMIA Pharmazeutika GmbH
• SuperSonic Imagine SA
• FUJIFILM Visualsonics Inc.
• Leriva Pharma SA
• Samsung Healthcare
• Jodas Expoim Pvt Ltd.
• nanoPET Pharma GmbH
• Alpinion Medical Systems
• Acusphere Inc.
• ContextVision AB
• Teratech Corporation
• Solstice Pharmaceuticals B.V.
Regional Dominance: Which Area Leads the Global Contrast Enhanced Ultrasound Market?
North America was the largest region in the contrast-enhanced ultrasound market in 2024
